All-trans-retinoic acid (ATRA) induces myeloid differentiation of a human promyelocytic leukemia cell line, NB4, but does not affect its subclone NB4/RA harboring a point-mutated ligand-binding domain (AF2) in retinoic acid receptor ␣ (RAR␣) gene. We found that ATRA induced the 4-fold elevation of acid sphingomyelinase (ASMase) activity 24 h after treatment in NB4 cells, but not in NB4/RA cells. ATRA did not affect neutral sphingomyelinase activity in either NB4 or NB4/RA. Upon treatment with ATRA, ceramide, the product of an ASMase reaction, accumulated in NB4 cells. Northern blot analysis showed a marked elevation of the ASMase mRNA 8 h after ATRA treatment, reaching a plateau at 24 h. Regulation of ASMase gene expression was studied by a promoter analysis using luciferase reporter assay. The 5-upstream flanking region of human ASMase gene (؊519/؉300) conjugated with the luciferase gene was introduced into COS-7 cells. Luciferase activity in transformed cells markedly increased in response to ATRA stimulation when the wild type RAR␣ or the PML/RAR␣ hybrid protein was co-expressed. Deletion experiments revealed that a short sequence at the 5-end (؊519/؊485) was indispensable for the ATRA response. Within this short region, two retinoic acid-responsive element-like motifs (TGCCCG and TCTCCT) and one AP2-like motif (CCCTTCCC) were identified. Deletion and base-substitution experiments showed that all three motifs are required for the full expression induced by ATRA. Electrophoresis mobility shift assays with the nuclear extract of ATRA-treated NB4 cells showed that proteins were bound specifically to the probe being mediated by all three motifs in the promoter sequence.
Extensive reports have suggested the significance of sphingomyelin metabolism in the intracellular signal transduction that leads cells to apoptosis, differentiation, or proliferation (1) (2) (3) . Despite numerous studies, the precise function of sphingomyelin-metabolizing enzymes is still obscure, and some of the observations made appear to be controversial (4) .
Sphingomyelinase is responsible for the first step of the sphingomyelin-catabolic pathway and produces ceramide, the potent bio-active lipid that may be involved in various important cellular processes (3, 4) . Sphingomyelinase is roughly classified into two major groups, acid and neutral sphingomyelinases (ASMase 1 and NSMase) by their optima pH (5) . ASMase is located in the acidic compartment, lysosome/endosome, and is involved in membrane turnover. Recent cloning of human (6) and mouse (7) ASMase genes has elucidated additional significant physiological and pathophysiological functions of ASMase. Genetic studies using ASMase knock-out mouse or lymphocytes from Niemann-Pick disease type A patients lacking functional ASMase have implicated ASMase in the signal transduction of apoptosis (5, 8, 9) . Recently, Langmann et al. (10) reported that lysosomal ASMase activity was induced during monocytic differentiation of monocytic leukemia cell line, THP-1, by 12-O-tetradecanoylphorbol-13-acetate (TPA) or 1␣,25-dihydroxyvitamin D 3 (Vit D 3 ), and that up-regulation of ASMase gene expression was mediated through SP1 and AP2 sites on the 5Ј-promoter region (10) .
Retinoids exert a wide variety of profound effects on embryonic development, cell proliferation, differentiation, and homeostasis (11) . The pleiotropic effects of retinoids are mediated through two classes of receptors, retinoic acid receptor (RAR) and retinoid X receptor (RXR) which belong to the superfamily of ligand-inducible transcription factors including steroid hormone, thyroid hormone and vitamin D 3 receptors (12) . The RAR receptors (RAR␣, -␤, -␥, and their isoforms) are activated by both all-trans (ATRA)-and 9-cis (9-cis-RA)-retinoic acids, whereas RXR receptors (RXR␣, -␤, -␥) are activated exclusively by 9-cis-RA (13) . RAR and RXR contain two regions of transcriptional activation functions (AFs) located in the N-terminal A/B region (AF1) and in the C-terminal ligand-binding E region (AF2), which may synergistically, and to some extent differentially, activate various retinoic acid-responsive promoters (13) . The activation of retinoic acid-responsive promoters most likely occurs through RAR/RXR heterodimers rather than through each homodimer. The heterodimer activated by ATRA or 9-cis-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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RA, specifically binds to retinoic acid-responsive elements (RARE) in the 5Ј-promoter regions of targeting genes, and activates the promoters' activity (14, 15) .
Acute promyelocytic leukemia (APL) is characterized by a reciprocal chromosomal translocation, t(15:17) that fuses the PML gene with the RAR␣ gene and generates a chimeric PML-RAR␣ (16) . The fusion protein carries the functional domains of RAR␣ including both DNA-and ligand-binding domains, and retains the ability to respond to ATRA (16) that has been known to bring remission in APL patients by inducing the differentiation of leukemic cells (17) . Elucidation of the molecular mechanism of ATRA-induced APL cell differentiation is thus important for developing a differentiation chemotherapy. There are several useful cell lines for analysis of the molecular mechanism of ATRA-induced APL cell differentiation (18, 19) . NB4 is a cell line derived from an APL patient and its myeloid differentiation is induced by ATRA. The ATRA-resistant NB4 subclone NB4/RA has a Pro(CCG) to Leu(CTG) substitution at codon 900 (type L) in the AF2 domain of RAR␣ (20) . The resulting PML-RAR␣ fusion of NB4/RA protein no longer retains ATRA-binding capacity.
In the present study, we found the ATRA-dependent elevation of ASMase activity in NB4 accompanied by an increase in intracellular ceramide. Analyses of the 5Ј-promoter region of the ASMase gene revealed the presence of functional ATRA responsive motifs and AP2-like sequence. Although one of the important roles of ATRA is well known to be the induction of differentiation in a variety of tumor cell lines (21) , less information is available on the involvement of ASMase or ceramide in ATRA-induced cell differentiation. This report describes the molecular mechanism of the ATRA-dependent induction of ASMase and suggests the possible involvement of ASMase in ATRA-induced APL cell differentiation.
EXPERIMENTAL PROCEDURES
Cell Culture-A human APL cell line, NB4 (18) and its ATRA-resistant clone, NB4/RA (20) , were cultured in 10% fetal calf serum in RPMI 1640 medium at 37°C in humidified air and 10% CO 2 . ATRA was added to the culture medium at 10 Ϫ6 M. ATRA, 9-cis-RA, 13-cis-RA, TPA, and Vit D 3 were purchased from Sigma.
Sphingomyelinase Activity-Cells were suspended in the hypotonic buffer containing 1 mM NaCO 3 , 2 mM CaCl 2 , 1 mM NaHSO 3 , 1 mM benzamidine, and 0.1 mM phenylmethylsulfonyl fluoride, and sonicated for 20 s. The resultant homogenate (2ϳ4 g of protein/l) was used for the assay of ASMase. Enzymatic activity of sphingomyelinase was measured by the formation of radioactive phosphocholine from [N-methyl- 14 C]sphingomyelin (Amersham Biosciences, Inc., Piscataway, NJ). The assay mixture for ASMase contained 0.1 mM acetate buffer, pH 5.8, 1 mM EDTA, 22 M [N-methyl- 14 C]sphingomyelin (20,000 cpm, adjusted by cold sphingomyelin), 0.05% Triton X-100, 1.2 M KCl, and 10 -20 g of protein of cell homogenate in a total volume of 50 l. The assay mixture for NSMase contained 0.1 M Tris/HCl, pH 7.0, 1 mM dithiothreitol, 10 mM MgCl 2 , 0.05% Triton X-100, 1.2 M KCl, 22 M [N-methyl- 14 C]sphingomyelin (20,000 cpm), and 15-30 g of protein of cell homogenate in a total volume of 50 l. After incubation for 30 min at 37°C, reactions were terminated by the addition of 4 volumes of chloroform/methanol (2:1, v/v). After centrifugation, the radioactivity of phosphocholine recovered from the upper layer was determined by liquid scintillation counter.
Analysis of Cell Differentiation-Cells were seeded at a density of 2 ϫ 10 5 cells/ml with or without 10 Ϫ6 M ATRA. At the indicated time points, cells were washed with cold phosphate-buffered saline and harvested. Cell viability was examined by the trypan blue dye exclusion test. Myeloid differentiation was evaluated by nitro blue tetrazolium (NBT) reduction activity (20) . Briefly, the cells added to TPA (0.04 g/ml) and NBT (1 mg/ml) (Sigma) were incubated at 37°C for 15 min, and then loaded on the slide glass and stained with Safuranin-O (Sigma). Positively stained cells were counted in groups of 500 cells under the microscope.
Northern Blot Analysis-For RNA preparation, cells were seeded at a density of 8 ϫ 10
5 cells/ml with or without 10 Ϫ6 M ATRA. After incubation for the indicated times, cells were washed with ice-cold phosphate-buffered saline and harvested. Total RNA was extracted using the RNAeasy kit (Qiagen K.K., Tokyo, Japan) according to the manufacturer's instructions. Ten g of total cellular RNA was separated on 1% agarose gel containing 2.2 M formaldehyde and transferred onto Zeta-probe membranes (Bio-Rad, Hercules, CA). After prehybridization, membranes were incubated with cDNA labeled by random priming in the presence of [␣- 32 P]dCTP using the Klenow fragment of E. coli DNA polymerase I (Megaprime TM DNA labeling system, Amersham Biosciences Inc.). ASMase cDNA were provided by Dr. Y. Hirabayashi (Brain Center, Riken Institute, Tochigi, Japan). Blots were exposed to immunoprecipitation plates for 24 h and visualized with a BAS 2000 image analyzer system (Fuji Film Co., Tokyo, Japan). The half-life of RNA was calculated with the sequential analysis of the message level in Northern blotting using cells cultured in 10 g/ml actinomycin D (Sigma) as described by Tennyson et al. (22) .
Quantitative Analysis of Different Ceramide Species-Various ceramide species were quantitatively determined by electrospray ionization tandem mass spectrometry (ESI-MS/MS, API 300 system, TakaraShuzo, Japan) according to the methods of Liebisch et al. (23) . Briefly, the cultured cells with or without 10 Ϫ6 M ATRA for each 12-and 24-h period were washed with cold phosphate-buffered saline and harvested. Total lipids were extracted by 20 volumes of chloroform/methanol (2:1, v/v) according to Folch's method, as described previously (24) , and subjected to mild alkaline hydrolysis. The alkaline-stable and organic solvent-soluble fraction was used as a sample of ceramide determination. Each sample equivalent to 250 g of protein of cell lysate was solubilized in 1 ml of 5 mM ammonium formate in methanol/chloroform (3:1, v/v), and C8-ceramide (Matreya, Inc.) at 0.3 M was added as an internal standard. The intensity ratios to the internal standard peak of the different ceramide species peak were calculated. Different concentrations of naturally occurring ceramides, C16:0, C18:0, C24:0, and C24:1 (Sigma) were analyzed, and quantitative fragmentation was confirmed.
Plasmids-The plasmids of RAR␣, mutated RAR␣, PML/RAR␣, and PML/mutated RAR␣ described before (25) were the generous gift of Dr. W. H. Miller (McGill University, Quebec, Canada). Luciferase reporter gene containing the putative 5Ј-promoter region (Ϫ519/ϩ300) of the human ASMase gene (10) was the kind gift of Dr. G. Schmitz (Regensburg University, Regensburg, Germany). It was cloned into PGL3 basic vector (Promega, Madison, WI) using KpnI and HindIII restriction enzyme sites. Deletion mutants of Ϫ519/ϩ300 (full-length) promoter were made by utilizing the unique restriction enzyme sites, AatI, SacI, BstII, PvuII, SacII, and SmaI. After the double digestion of full-length promoter plasmid with HindIII and each enzyme described above, the respective fragment was cut out from the gel, purified, and ligated again into the PGL3 basic vector. The products were confirmed by size fractionation through gel electrophoresis. To make the deletion mutants lacking A (TGCCCG), B (TCTCCT), and A, B, and AP2 (CCCT-TCCC) regions as shown in Fig. 8A , top panel, the following PCR primers were made. The respective sense primers for preparing the mutant swith either A or B deletions were 5Ј-GGGGGTACCTCTCTC-CTACCTCCCCTTCC-3Ј and 5Ј-GGGGGTACCCGATCCTGCCCGCCC-TGCTCCCTTCCCGGG-3Ј. The sense primer for mutants with total deletions of A, B, and AP2 was 5Ј-GGGGGTACCGGGTCGGTCTGGC-AGCTATT-3Ј. Respective primers for the base-substituted mutants in A, B, AP2, or a nonspecific region as shown in Fig. 8B (top panel) were 5Ј-GGGGGTACCCGATCCTCGATGCCCTGCT-3Ј, 5Ј-GGGGGTACCC-GATCCTGCCCGCCCTGCTCAGGATAACCTCCCCTT-3Ј, 5Ј-GGGGG-TACCCGATCCTGCCCGCCCTGCTCTCTCCTACCTCATATGCACGG-GCTAAACG-3Ј and 5Ј-GGGGGTACCCGATCCTGCCCGCCGATGCCT-CTCCTACCT-3Ј. The common antisense primer was 5Ј-GACTCTCCC-TGAGGTCACCA-3Ј. The respective PCR product was digested with KpnI and BstII enzymes, precipitated with ethanol, and ligated again to a KpnI/BstII-digested product of the full-length ASMase promoter (Ϫ519/ϩ300) plasmid described above. All plasmid constructs were confirmed by direct sequence using an ABI PRIMSM TM 310 Genetic Analyzer (PE Biosystems Japan, Chiba, Japan).
Transfection and Luciferase Assays-COS-7 cells were cultured in 10% fetal calf serum in Dulbecco's modified Eagle's medium. One day before transfection, 10 5 cells were plated in Falcon 3001 plates (35 ϫ 10 mm, Becton-Dickinson, Franklin Lakes, NJ). A single experiment was carried out with three independent cultures, and the experiment was repeated at least 3 times. Transfection was performed using LipofectAMINE Ace TM (Invitrogen, Gaithersburg, MD) according to the manufacturer's recommendation. Briefly, 5 g of RAR␣ plasmid or a related plasmid, 5 g of luciferase reporter plasmid containing various length of 5Ј promoter of human ASMase, and 1 g of ␤-galactosidase expression plasmid (Promega) were mixed with 10 l of LipofectAMINE reagent. The mixture was diluted to 1 ml using OPTI-MEM TM (Invitrogen), and added to the pre-washed COS-7 cells. Twenty-four hours after transfection, medium was changed to 10% fetal calf serum in Dulbecco's modified Eagle's medium with or without 10 Ϫ6 M ATRA, and was incubated for an additional 2 days. Cells were washed and cell lysates were prepared using a Picca Gene kit (Toyo Ink Co., Tokyo, Japan). Twenty l of cell lysates was mixed with 100 l of Picca gene assay buffer and their luciferase activity was measured by Lumat luminometer (Mini Lumat, LB9506, Berthold GmbH & Co., Bad Wildbad, Germany). ␤-Galactosidase activity was measured simultaneously using a ␤-galactosidase assay kit (Promega). The relative promoter activity was normalized with ␤-galactosidase activity as the transfection efficiency.
Preparation of Nuclear Extract-Cells were seeded at 8 ϫ 10 5 /ml and cultured with or without 10 Ϫ6 M ATRA for 24 h. The harvested cells were subjected to a preparation of nuclear extract according to the method of Langmann et al. (10) . Briefly, the cells were lysed in hypotonic buffer containing 0.1% Nonidet P-40 on ice for 5 min and then centrifuged. The pelleted nuclei were incubated at 4°C for 15 min with gentle vortexing in the buffer containing 20 mM HEPES, pH 7.9, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, and 10% glycerol. After centrifugation, the supernatant was used as a nuclear extract.
Electrophoresis Mobility Shift Assay (EMSA)-Oligonucleotides used for EMSA were: sense 1 (the sequence corresponding to Ϫ518/Ϫ478 of 5Ј-region of ASMase gene), 5Ј-GATCCTGCCCGCCCTGCTCTCTCCTA-CCTCCCCTTCCCGG-3Ј; sense 2 (lacking A from sense 1), 5Ј-ACCTC-CCCTTCCCGGGCTAAA-3Ј; sense 3 (lacking B from sence 1), 5Ј-GAT-CCTGCCCGCCCTGCTCACCTCCCCTTCCCGG-3Ј; sense 4 (lacking AP2-like sequence from sense 1), 5Ј-GATCCTGCCCGCCCTGCTCTCT-CCTACCTC-3Ј; sense 5 (lacking both A and B from sense 1), 5Ј-ACCT-CCCCTTCCCGG-3Ј. The sense and the corresponding antisense oligonucleotides were radiolabeled by [␥-
32 P]ATP (Amersham Biosciences, Inc.) and T4 kinase (New England Biolabs Inc., Japan), purified by a G-25 column and then annealed. Six g of protein of nuclear extract described above was incubated at room temperature for 30 min with 2 g of poly(dI-dC) (Pharmacia Corp.) and 0.4 pmol of 32 P end-labeled probes (100,000 cpm) in the binding buffer containing 50 mM HEPES, pH 7.9, 6 mM MgCl 2 , 50 mM KCl, and 5 mM dithiothreitol, adjusting the total volume to 10 l. The DNA-protein complex was analyzed on a 5% polyacrylamide gel using 1 ϫ TBE as the electrophoresis buffer. Gels were exposed to immunoprecipitation plate for 1 h and visualized with a BAS 2000 system. In a competition experiment, nuclear extracts were preincubated for 10 min with a 1-100-fold molar excess of non-labeled competitor oligonucleotide. The antibodies used for neutralization were as follows: anti-RAR␣ rabbit polyclonal antibody raised against the N-terminal of RAR␣ (Santa Cruz Biotechnology, Santa Cruz, CA, catalog sc-551); anti-RXR␣ rabbit polyclonal antibody (N197) raised against an epitope corresponding to amino acids 198 -462 of RXR␣ (Santa Cruz Biotechnology, catalog sc-774), and normal rabbit IgG (Santa Cruz Biotechnology). Each antibody was diluted 100 times and preincubated with nuclear extract at room temperature for 15 min.
RESULTS

ATRA Induces
ASMase, but Not NSMase-We treated human APL cell lines with or without 10 Ϫ6 M ATRA. Fig. 1 shows the time course of the myeloid differentiation process of NB4, and of its ATRA-resistant subclone, NB4/RA. NB4 cell growth was gradually inhibited during 3 days in the presence of ATRA. Myeloid differentiation of the cells was assessed by NBT reduction activity (see "Experimental Procedures"). On day 5 of ATRA treatment, the number of cells stained with Safranin-O increased up to 70% of NB4 cells. On the other hand, NB4/RA showed neither the inhibition of cell growth nor the induction of myeloid differentiation in the presence of ATRA.
Activities of ASMase and NSMase during the differentiation process were measured with extracts from NB4 and NB4/RA cells that had been cultured in the presence or absence of ATRA. ASMase activity of NB4 gradually increased from 6 to 8 h after ATRA treatment, reached maximum (4-fold increase) after 24 h, and maintained a plateau thereafter (Fig. 2A) . NSMase activity did not change during the same time course (data not shown). In contrast, ASMase activation in NB4/RA did not increase by ATRA treatment (Fig. 2B) . Up-regulation of ASMase activity in NB4 was also obtained by treatment with 9-cis-RA, 13-cis-RA, or TPA (Fig. 3A) . Vit D 3 also stimulated ASMase activity in NB4 but to a lesser extent (Fig. 3A) . The up-regulation by these reagents was confined only to NB4 and not observed in NB4/RA, except that with TPA (Fig. 3) . It was remarkable that TPA increased ASMase activity of NB4/RA to a level comparable to that of NB4 (Fig. 3, A and B) , indicating a RAR␣-independent pathway of the TPA action as described by Langmann et al. (10) .
Induction of ASMase Accompanied with an Increase in Intracellular Ceramide Content-We quantified various ceramide species using ESI-MS/MS spectrometry. In ATRA-treated NB4 cells, each ceramide content remained nearly the same as that of non-treated NB4 until 12 h after ATRA treatment (Fig. 4A) . At 24 h, some species of ceramide with long fatty acid chains such as C22:0, C24:0, and C24:1 increased approximately up to 3-fold (Fig. 4B) . Again, NB4/RA did not show any increase in ceramide content by ATRA treatment (data not shown). The highly expressed ASMase in ATRA-treated NB4 might catalyze sphingomyelin hydrolysis to produce a large amount of ceramide.
ATRA Activates Transcription of ASMase Gene-Northern blot analysis showed that the amount of ASMase mRNA in NB4 increased 2.4-fold 24 h after ATRA treatment (Fig. 5) . On the other hand, ASMase mRNA in NB4/RA did not increase following ATRA (Fig. 5) . Experiments with actinomycin D indicated that the half-life of ASMase mRNA was essentially the same with and without ATRA treatment (data not shown). The mRNA of NB4/RA did not increase by ATRA (Fig. 5) . These results strongly suggest that the increase in ASMase activity in ATRA-treated NB4 is due to the activated transcription of ASMase gene. ATRA-responsive element (RARE) in the 5Ј-flanking region of the ASMase gene, we carried out a luciferase reporter assay. In this experiment, we used COS-7 cells for a transient expression of the reporter gene because neither NB4 nor NB4/RA was tolerant of DNA transfection. Expression plasmids carrying ATRA receptor-related genes, luciferase gene-conjugated 5Ј-region (Ϫ519/ϩ300) of the ASMase gene, and ␤-galactosidase gene (transfection marker) were simultaneously co-transfected into COS-7 by the lipofection method. When wild type RAR␣ was co-transfected in cells, luciferase activity increased in response to ATRA treatment 4.5-fold compared with the nontreated control (Fig. 6 ). Co-expression of PML/RAR␣ hybrid molecule also supported a 2.5-fold increase of luciferase expression (Fig. 6) . On the other hand, co-expression of the mutated RAR␣ or PML-mutated RAR␣ hybrid molecule did not support the ATRA-dependent enhancement of gene expression (Fig. 6) . These results strongly suggest that some kind of ATRA-responsive elements exists in this 5Ј-flanking region.
ATRA-responsive Elements Exist in the 5Ј-Promoter Region of
To locate more precisely the sequences that are responsible for the ATRA induction, we prepared a deletion series of a 5Ј-flanking sequence of the ASMase gene (Fig. 7, top panel) . Using these constructs, ATRA-induced luciferase activities were measured in the presence of co-expressed RAR␣ (Fig. 7) . Unexpectedly, all kinds of deletions resulted in a remarkable decrease in ATRA-inducible luciferase activity compared with the full-length (Ϫ519/ϩ300). Since the shortest deletion of 108 bases from 5Ј-end abolished the induction almost completely, putative responsive elements might exist in this region. Within the Ϫ519 to Ϫ411 sequence, we found two putative RARErelated sequences, TGCCCG (motif A) and TCTCCT (motif B) (Fig. 8A, top panel) . These sequences closely resembled the previously reported ones, TGCCCT and TGTCCT of human surfactant protein B promoter (26, 27) , and TGCCCG and TGTCCT of the retinol-binding protein gene (28) . Furthermore, we found an AP2-like motif (CCCTTCCC) in the near position to B motif (Fig. 8A, top panel) . We focused on A, B, and AP2 motifs, and made the new deletion series: DelA, lacking Ϫ519 to Ϫ502 including A motif; DelB, lacking Ϫ502 to Ϫ492 including B motif; DelAB and AP2, lacking Ϫ519 to Ϫ468 including all of A, B, and AP2 motifs (Fig. 8A, top panel) . They were transfected to COS-7 cells co-expressing RAR␣ and the ATRAinduced luciferase activities were measured. Again, all of the deletions abolished the induction capacity (Fig. 8A) . It is suggested that both A and B motifs are essential for ATRA-dependent activation of ASMase promoter. To demonstrate this possibility and to examine the involvement of AP2 motif on the activation of ASMase promoter, we introduced the base substitution in A, B, and AP2 motifs, and further in a nonspecific site: Mt A, substituting TGCCCG to TCGATG in A motif; Mt B, substituting TCTCCT to AGGATA in B motif; Mt AP2, substituting CCCTTCCC to ATATGCAC in AP2 motif; Mt, substituting CTGCT to GATGC in nonspecific site (Ϫ501 to Ϫ505) between A and B motifs (Fig. 8B, top panel) . As expected, all of each substitution in A, B, and AP2 motifs resulted in a loss of ATRA-dependent activation of luciferase activity, however, the substitution in nonspecific site showed only a faint loss (Fig.  8B) . These results clearly indicate that not only A and B motifs but also AP2 motif is essential for ATRA-dependent activation of ASMase promoter. tion would occur by binding of protein factors to the responsive sites of ASMase promoter region. The ATRA-dependent binding of proteins to the promoter region was investigated by EMSA using a nuclear extract of NB4 cells. A 47-mer oligonucleotide DNA, corresponding to the Ϫ518 to Ϫ478 of the ASMase promoter region, was synthesized, labeled with 32 P, and annealed with a complementary strand (DS oligo-1 in Fig. 9 ).
ATRA-dependent Binding of Nuclear Protein(s) to ASMase
When treated with ATRA, NB4 nuclear extract gave multiple shifted bands migrating much slower than unbound probes (indicated by arrow, Fig. 9A, lane 3) . The shifted bands were not observed with the non-treated control (Fig. 9A, lane 4) . Furthermore, they were not observed with NB4/RA despite ATRA treatment (Fig. 9A, lane 5) , which is consistent with its ATRA-refractory characteristics (Fig. 1) . The shifted bands produced by nuclear extract from ATRA-treated NB4 were dose dependently competed out by the addition of unlabeled DS oligo-1 (Fig. 9B) . Pretreatment of nuclear extract with an anti-RAR␣ antibody also decreased the intensity of the shifted bands (Fig. 9C, lane 2) , whereas an anti-RXR␣ antibody decreased the intensity moderately (Fig. 9C, lane 3) , and normal rabbit IgG did not affect the band at all (Fig. 9C, lane 4) . No single antibody alone interacted with DS oligo-1 (data not shown). Therefore, the shifted bands may be due to the specific binding proteins generated by the ATRA treatment of NB4 cells expressing the wild type RAR␣. Formation of the shifted bands required intact sequences of A motif, B motif, and the AP2-like motif of the promoter region, since oligomers that lack either one of these sequences failed to form shifted bands (Fig.  10, lanes 2-5) . The EMSA results, therefore, are consistent with the promoter activity measured in COS-7 co-expressing RAR␣ (Fig. 8, A and B) . RAR␣ or its related genes (mutated RAR␣, PML/RAR␣, or PML/mutated RAR␣), luciferase reporter gene containing the 5Ј-promoter of human ASMase (Ϫ519/ϩ300) and ␤-galactosidase gene were co-transfected simultaneously into COS-7 cells by the lipofection method as described under "Experimental Procedures." One day after transfection, COS-7 cells were treated with (ϩ) or without (Ϫ) 10 Ϫ6 M ATRA for another 2 days, and luciferase and ␤-galactosidase activities were determined with cell lysate as described under "Experimental Procedures." The ordinate shows the relative luciferase activity (ratio of luciferase activity to ␤-galactosidase activity). Each relative luciferase activity without 10 Ϫ6 M ATRA in each experiment was defined as 1, and the fold stimulation with ATRA was calculated. The results reveal the mean Ϯ S.D. of three independent experiments. Each experiment was performed in triplicate. RAR␣ or its related genes are designated on the abscissa.
by Vit D 3 functions as a lipid mediator/second messenger in HL-60 cell differentiation (30) . Since then, numerous works have demonstrated the key role of ceramide in signal transduction, which leads cells to proliferation, differentiation, cell cycle arrest, or apoptotic death (1-3) . Besides Vit D 3 , a variety of other agents such as tumor necrosis factor ␣, nerve growth factor, interleukin-1, and progesterone have been proposed as inducers of cell differentiation as well as stimulators of ceramide production through activation of sphingomyelin hydrolysis (4) .
Some reports suggested ceramide to be the functional molecule in ATRA-inducible cell differentiation (31-34). Bertolaso et al. (31) showed that the accumulation of both ceramide and catalytically active protein kinase C-in nuclei plays a key role in the induction of granulocytic differentiation of HL-60 by ATRA. Riboni et al. (32) reported the important contribution of two metabolic pathways, de novo ceramide biosynthesis and sphingomyelin degradation by NSMase in the differentiation of neuroblastoma Neuro2A cells by ATRA. In the present study, we investigated the relationship between ATRA-induced myeloid differentiation of APL cells and the function of ASMase in terms of gene transcription, ASMase activity, and the increase in intracellular ceramide content, using two cell lines, ATRAresponsive NB4 and its mutant, ATRA-resistant NB4/RA.
NB4 has a chromosomal translocation, t(15;17) and generates the PML-RAR␣ fusion protein. PML-RAR␣ retains an active ligand-receptor domain (AF2) for ATRA (11) . Under the pharmacological concentration of ATRA, NB4 differentiates toward myeloid-like cells at 70% efficiency 5 days after ATRA treatment (Fig. 1A) . On the other hand, NB4 subclone NB4/RA did not show ATRA-dependent differentiation as reported by Kitamura et al. (20) (Fig. 1B) . ASMase activity of NB4 began to increases 8 h after ATRA treatment and reached a plateau at 24 h, (but not of NB4/RA) (Fig. 2) . 9-cis-RA, which activates RAR␣ and induces myeloid differentiation of NB4 at the same efficiency as ATRA (20) , also increased the ASMase activity of NB4 but not of NB4/RA (Fig. 3) . Interestingly, TPA increased the ASMase activities of both NB4 and NB/RA (Fig. 3) . These results suggest that the ASMase induction in ATRA-treated NB4 depends on an ATRA receptor, RAR␣ which is activated either by binding of ATRA or by 9-cis-RA, and that TPA induces ASMase activity through any RAR␣-independent pathway in either NB4 or NB4/RA, as reported by Langmann et al. (10) .
We also found an ATRA-dependent increase of ASMase mRNA in NB4 by Northern blot analysis (Fig. 5) , suggesting the existence of RARE site(s) in the putative 5Ј-promoter region of the ASMase gene. Luciferase reporter assay showed the existence of a RARE site in the 5Ј-region, Ϫ519 to Ϫ411 of the ASMase gene (Fig. 7) . By a homology search of the DNA se- (top panel in B) . Each expression plasmid of the ASMase 5Ј promoter was co-transfected with RAR␣ and ␤-galactosidase plasmids to COS-7. Transfected cells were treated with (ϩ) or without (Ϫ) ATRA, and luciferase activity was determined as described under "Experimental Procedures." Each relative luciferase activity without 10 Ϫ6 M ATRA in each experiment was defined as 1, and the fold stimulation with ATRA was calculated. The results reveal the mean Ϯ S.D. of three independent experiments. Each experiment was performed in triplicate. Various human ASMase 5Ј promoter plasmids are designated along the abscissa.
quence of Ϫ519 to Ϫ411, we found RARE-like sites, TGCCCG (A motif) (Ϫ513 to Ϫ508) and TCTCCT (B motif) (Ϫ499 to Ϫ494) which closely resembled the core motifs of new RAREs reported by Panariello et al. (28) and Naltner et al. (26) . Luciferase reporter assay as well as EMSA showed the involvement of A and B sites in the activation of the ASMase gene promoter (Figs. 8 and 9) . Furthermore, the additional involvement of AP2-like motif (Ϫ488 to Ϫ481, CCCTTCCC) was suggested (Figs. 8B and 10) , just like the thyroid transcription factor-1 site which is a tissue-specific factor and stimulates human surfactant protein B promoter with the clustered RAREs, TGC-CCT, and TGTCCT (26) . Interestingly, AP2 is also reported to be a retinoic acid-inducible and cell-type specific transcription factor (35, 36) .
Which proteins bind to RARE sites of ASMase 5Ј-promoter region remains to be determined. Besides its basic function as a transcription factor, RAR␣ may function as a tethering protein, i.e. recruiting nuclear receptor co-activators in the presence of ATRA. DRIP/TRAP, which is a large macromolecular complex containing at least 15 nuclear receptor coactivators, depends on ATRA in binding to the retinoid receptor of NB4 (37) . Therefore, it is feasible that a DRIP/TRAP-like large coactivator complex is recruited by ATRA-activated RAR␣, and that it binds to the 5Ј-promoter region of the ASMase gene. In accord with this hypothesis, we found that at least three elements (A, B and AP2 motifs) are responsible for the transcriptional activation of the ASMase gene. According to this scenario, anti-RAR␣ antibody could inhibit the complex formation (Fig. 9C) either by inhibiting the DNA binding activity of RAR␣, or by blocking the interaction sites of RAR␣ with the co-activators.
In the present study, the participation of RXR and PML in the ASMase gene expression remains unknown. Activation of ATRA-responsive promoters most likely occurs through RAR/ RXR heterodimers rather than through RAR or RXR homodimers (14, 15) . In a transient transfection assay, we used either one of two plasmids, RAR␣ or RAR␣/PML, as a receptor source. Although cells may show ectopic expression of homodimers, luciferase activity is increased by the addition of ATRA. It is uncertain whether the endogenous RXR in COS-7 combines with the transfected RAR␣ or PML/RAR␣ to induce luciferase activation, or whether RAR␣ homodimer induces it.
In 99% of APL, RAR␣ is fused to the PML leading to the production of a PML-RAR␣ chimeric protein (38) . We showed that the transfection of the RAR␣ gene as well as PML/RAR␣ gene to COS-7 induced the activation of luciferase reporter gene by an ATRA addition (Fig. 6) . We have also observed the ATRA-induced elevation of ASMase activity in the human hepatoma cell line, Hep G2, under a low concentration of fetal calf serum (data not shown). These results suggest that the ATRAdependent activation of the ASMase gene transcription might be due to RAR␣, and that PML may not be responsible for the ASMase induction.
It is of great interest to know whether ATRA-induced ASMase is directly involved in the myeloid differentiation process. Sphingoid molecules have been known to modulate the expression of various genes such as c-myc, c-jun, c-fos, and bcl-2 during the fundamental cellular processes of cell proliferation, differentiation, and apoptosis (2) . In a model membrane system, ceramide showed a unique capacity to spontaneously selfaggregate into a microdomain such as a caveolae or raft (39) . In addition, in model membranes ceramide-rich microdomains tend to fuse rafts to form larger platforms (40) . This raises the possibility that the increase in cellular ceramide in ATRAtreated NB4 cells might induce the reorganization of a signaling structure in the microdomain. We propose that ASMase induction and the resultant ceramide production play a key role in the differentiation process of the NB4 cell line.
